December 18th According to a source quoted by the Financial Times, on the evening of the 17th local time, the U.S. Food and Drug Administration (FDA) decided to approve the emergency use of Moderna coronavirus vaccine.
It is reported that the FDA has notified Moderna that it will finalize and issue an emergency use authorization (EUA) for the coronavirus candidate vaccine as soon as possible.
Earlier that day, the FDA’s COVID-19 vaccine team recommended approval for the use of Moderna’s coronavirus vaccine. The group voted 20 to 4, with 1 abstention in favor of recommending the Modner vaccine to people over 18.
The team found that the Modna vaccine was safe and effective at 95%, according to evidence from a clinical trial of 30,400 people. FDA Administrator Stephen Hahn will officially approve the vaccine as early as late as the 17th, and start nationwide delivery on the 21st.
Moderna vaccine will be the second vaccine in the United States to prevent COVID-19. The U.S. Food and Drug Administration (FDA) approved the application for emergency use authorization (EUA) of the coronavirus vaccine from Pfizer and BioNTech on the 11th.